| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q04DX002 (ip) | median survival time | saline | 13.0 mg/kg/injection | 147.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 21.6 mg/kg/injection | 156.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 36.0 mg/kg/injection | 164.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 60.0 mg/kg/injection | 173.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on day 5 |
| Q04DX002 (ip) | median survival time | saline | 100.0 mg/kg/injection | 194.0 | Antitumor endpoint evaluated on day 35; 06/06 animals surviving on day 5 |